DrugPatentWatch Database Preview
Details for Patent: 9,006,256
Which drugs does patent 9,006,256 protect, and when does it expire?
This patent has fourteen patent family members in ten countries.
Summary for Patent: 9,006,256
Title: | Antitumor agent for thyroid cancer |
Abstract: | The present invention provides pharmaceutical compositions and therapeutic methods for treating diseases such as multiple endocrine neoplasia type IIA, multiple endocrine neoplasia type IIB, familial medullary thyroid carcinoma, thyroid carcinoma, papillary thyroid carcinoma, sporadic medullary thyroid carcinoma, Hirschsprung disease, pheochromocytoma, parathyroid hyperplasia and mucosal neuromas of the gastrointestinal tract. The therapeutic methods and pharmaceutical compositions use a RET kinase inhibiting substance, such as 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinoli- necarboxamide and pharmacologically acceptable salts thereof, and involve a step of administering the RET kinase inhibiting substance to a patient. |
Inventor(s): | Matsui; Junji (Tsukuba, JP) |
Assignee: | Eisai R&D Management Co., Ltd. (Tokyo, JP) |
Application Number: | 13/083,338 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 9,006,256
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Eisai Inc | LENVIMA | lenvatinib mesylate | CAPSULE;ORAL | 206947-001 | Feb 13, 2015 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | METHOD FOR TREATING THYROID CARCINOMA INCLUDING DIFFERENTIATED THYROID CANCER | ➤ Try a Free Trial | ||||
Eisai Inc | LENVIMA | lenvatinib mesylate | CAPSULE;ORAL | 206947-002 | Feb 13, 2015 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | METHOD FOR TREATING THYROID CARCINOMA INCLUDING DIFFERENTIATED THYROID CANCER | ➤ Try a Free Trial | ||||
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Patent Submitted |
International Patents Family Members for US Patent 9,006,256
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2007252506 | ➤ Try a Free Trial | |||
Canada | 2652442 | ➤ Try a Free Trial | |||
China | 101443009 | ➤ Try a Free Trial | |||
China | 104706637 | ➤ Try a Free Trial | |||
Country | Document Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |